Purified p75 (type II) tumor necrosis factor receptor polypeptides
US5945397A · kind A · utility
23Cited by
15References
52Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 16, 1996 |
| Grant date | Aug 31, 1999 |
| Priority date | — |
| Expiry date | May 16, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Human tumor necrosis factor receptor proteins having the of amino acids 1-235 are disclosed in SEQ ID NO:2. TNF receptor deletion variants having the sequence of amino acids 1-185 or 1-163 of SEQ ID NO:2 also display TNF bing activity. Murine TNF receptor proteins are also disclosed in SEQ ID NO:4 and are capable of binding TNF.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.